Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O4NR
|
||||
| Former ID |
DIB001923
|
||||
| Drug Name |
LTB4
|
||||
| Synonyms |
Leukotriene B4 agonist (HIV infection), LTB4 Sweden AB
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
LTB4 Sweden AB
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H32O4
|
||||
| InChI |
InChI=1S/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/b8-7+,9-6-,14-10+,15-11-/t18-,19-/m1/s1
|
||||
| InChIKey |
VNYSSYRCGWBHLG-AMOLWHMGSA-N
|
||||
| CAS Number |
CAS 71160-24-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
5240, 801682, 4266069, 7979751, 8143279, 8616293, 14753488, 15316444, 24896256, 26754791, 26754792, 26754793, 26759044, 39289598, 47217017, 47515561, 47811004, 48110702, 48259480, 48334747, 49964833, 50110780, 53790345, 53801088, 57357761, 79593894, 92126167, 92309780, 99300694, 99302212, 103256813, 103925923, 104046421, 113853357, 126523796, 127316819, 127316820, 127316821, 127316822, 127316823, 127316824, 127316825, 127316826, 127316827, 127316828, 127316829, 127316830, 127316831, 134341607, 135010128
|
||||
| Target and Pathway | |||||
| Target(s) | Leukotriene B4 receptor 1 | Target Info | Agonist | [533148] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| References | |||||
| Ref 521756 | ClinicalTrials.gov (NCT00251537) A Pilot Study of LTB4 in HIV-1 Infected Adults. U.S. National Institutes of Health. | ||||
| Ref 539612 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2487). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.